Indivior reported 7M in Interest Expense on Debt for its fiscal semester ending in March of 2026.





Interest Expense On Debt Change Date
AstraZeneca USD 340M 144M Jun/2026
Cassava Sciences USD 108.37M 396.06M Mar/2026
GlaxoSmithKline GBP 121M 46M Jun/2026
Glaxosmithkline GBP 192.73M 14.79M Mar/2026
Hikma Pharmaceutical USD 67M 47M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
West Pharmaceutical Services USD 1.9M 1.7M Mar/2026